Haptoglobin phenotype predicts cerebral vasospasm and clinical deterioration after aneurysmal subarachnoid hemorrhage.

[1]  Rajat Dhar,et al.  Relationship Between Angiographic Vasospasm and Regional Hypoperfusion in Aneurysmal Subarachnoid Hemorrhage , 2012, Stroke.

[2]  Joseph P Broderick,et al.  Definition of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage as an Outcome Event in Clinical Trials and Observational Studies: Proposal of a Multidisciplinary Research Group , 2010, Stroke.

[3]  S. Bandinelli,et al.  Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults , 2009, European Journal of Clinical Nutrition.

[4]  I. C. van der Schaaf,et al.  Diagnosing Delayed Cerebral Ischemia With Different CT Modalities in Patients With Subarachnoid Hemorrhage With Clinical Deterioration , 2009, Stroke.

[5]  P. Ascenzi,et al.  Human haptoglobin structure and function – a molecular modelling study , 2008, The FEBS journal.

[6]  A. Levy,et al.  Rate of nitric oxide scavenging by hemoglobin bound to haptoglobin. , 2008, Nitric oxide : biology and chemistry.

[7]  R. Tamargo,et al.  Haptoglobin 2-2 Genotype Determines Chronic Vasospasm After Experimental Subarachnoid Hemorrhage , 2007 .

[8]  Douglas J. Fox,et al.  Update on evidence for a genetic predisposition to cerebral vasospasm. , 2006, Neurosurgical focus.

[9]  Jose I Suarez,et al.  Aneurysmal subarachnoid hemorrhage. , 2006, The New England journal of medicine.

[10]  A. Levy,et al.  Haptoglobin and the development of cerebral artery vasospasm after subarachnoid hemorrhage , 2006, Neurology.

[11]  P. Visca,et al.  Hemoglobin and heme scavenging , 2005, IUBMB Life - A Journal of the International Union of Biochemistry and Molecular Biology.

[12]  Yunling E. Du,et al.  Effect of Cisternal and Ventricular Blood on Risk of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage:: The Fisher Scale Revisited , 2001, Stroke.

[13]  I. Hochberg,et al.  Haptoglobin phenotype and vascular complications in patients with diabetes. , 2000, The New England journal of medicine.

[14]  J. Delanghe,et al.  Biological and clinical significance of haptoglobin polymorphism in humans. , 1996, Clinical chemistry.

[15]  J. Gutteridge,et al.  Lipid peroxidation and antioxidants as biomarkers of tissue damage. , 1995, Clinical chemistry.

[16]  K. Fox,et al.  Hemoglobin Inhibits Endothelium‐Dependent Relaxation to Acetlcholine in Human Coronary Arteries In Vivo , 1993, Circulation.

[17]  R. Macdonald,et al.  A review of hemoglobin and the pathogenesis of cerebral vasospasm. , 1991, Stroke.

[18]  M. Vermeulen,et al.  Prediction of delayed cerebral ischemia, rebleeding, and outcome after aneurysmal subarachnoid hemorrhage. , 1988, Stroke.

[19]  I. Tatarsky,et al.  Serum haptoglobin types and leukemia , 1986, Human Genetics.

[20]  N. Kassell,et al.  Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. , 1985, Stroke.

[21]  R. Galen,et al.  Evaluation of a nephelometric assay for haptoglobin and its clinical usefulness. , 1979, Clinical chemistry.

[22]  J. Javid.  The Effect of Haptoglobin Polymer Size on Hemoglobin Binding Capacity * , 1965, Vox sanguinis.

[23]  E. Minar,et al.  Haptoglobin phenotype 2-2 as a potentially new risk factor for spontaneous venous thromboembolism. , 2005, Haematologica.

[24]  J. Wassell.  Haptoglobin: function and polymorphism. , 2000, Clinical laboratory.

[25]  Fisher Cm,et al.  Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. , 1980, Neurosurgery.